Evidence map›Paper›PMID 39966745›Full record

ArticleBMC cancer2025

Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment.

Davide Smussi, Carlo Conti, Luigi Lorini, Davide Mattavelli, Rosella Levaggi, Raffaele Miniaci, Stefano Calza, Alberto Deganello, Consiglia Paduano, Andrea Alberti and 5 more

Abstract readValidation Study
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Davide Smussi *Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
Carlo Conti *Unit of Otorhinolaryngology and Head and Neck Surgery, ASST-Spedali Civili, Brescia, Italy.
Luigi LoriniMedical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, Milan, 20089, Italy.
Davide MattavelliUnit of Otorhinolaryngology and Head and Neck Surgery, ASST-Spedali Civili, Brescia, Italy.
Rosella LevaggiDepartment of Economics and Management, University of Brescia, Brescia, Italy.
Raffaele MiniaciDepartment of Economics and Management, University of Brescia, Brescia, Italy.
Stefano CalzaBiostatistics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Alberto DeganelloOtolaryngology Head and Neck Surgery Department, IRCCS National Cancer Institute (INT), Milan, 20133, Italy.
Consiglia PaduanoMedical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, Milan, 20089, Italy.
Andrea AlbertiMedical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
Salvatore GrisantiMedical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
Carla Ida RipamontiDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Alfredo BerrutiMedical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
Cesare PiazzaUnit of Otorhinolaryngology and Head and Neck Surgery, ASST-Spedali Civili, Brescia, Italy.
Paolo BossiMedical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, Milan, 20089, Italy. paolo.bossi@hunimed.eu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFinancial toxicity from cancer treatments is rising as an important patient-reported outcome. Its relevance was first assessed in the context of privately financed healthcare system, where the financial hardship caused by out-of-pocket payments negatively affects survival, while fewer evidence exists on its role in countries where care is financed by the public health care system. Head and Neck Cancer (HNC) patients face an increased risk for financial toxicity due to multimodal treatment and relevant out of pocket costs. The aim of this study was to develop and validate an Italian version of the Canadian Financial Index of Toxicity (FIT) questionnaire, defined FITALY.

methodsFIT questionnaire was translated through a forward-backward process by two investigators independently, and the process was reviewed by a certified medical scientific English native speaker. Once reached consensus upon Italian translation, two Health Economics experts were consulted to adapt the questionnaire to Italian socio-economic context. The FITALY questionnaire v1.0 hereby developed was anonymously administered to two consecutive groups of 30 patients who had received curative, multimodal treatment for HNC cancer at ASST Spedali Civili of Brescia, Italy. A cognitive debriefing form was simultaneously administered to ask patients to exclude recurring and redundant items and include new relevant items.

resultsThe 14-item FITALY questionnaire provides a global evaluation of financial toxicity ranging from 0 to 100. The questionnaire is divided into 4 domains: financial burden (6 items), exploring the objective financial toxicity burden; financial distress (2 items), which refers to the psychological distress related to financial toxicity; out-of-pocket costs (4 items), which focus on medical expenses paid by the patient; and loss of productivity (2 items), that investigates the disease impact on both patient's and caregiver's job activity.

conclusionsStarting from the Canadian 9-item FIT questionnaire, we developed and validated the Italian 14-item FITALY questionnaire. Prospective application to a cohort of Italian HNC patients is ongoing.

Indexed as

Financial StressHead and Neck NeoplasmsHealth ExpendituresAdultAgedCombined Modality TherapyFemaleHumansItalyMaleMiddle AgedSurveys and QuestionnairesFinancial toxicityHead and neck cancerPatient financial burdenQuestionnaire development and validationSupportive care

Identifiers

PMID39966745
PMCPMC11834550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.